Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.

Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. Ann Oncol. 2008 Oct; 19(10):1787-94.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Squamous Cell
Cohort Studies
Combined Modality Therapy
Disease-Free Survival
Dose-Response Relationship, Radiation
Female
Fluorouracil
Head and Neck Neoplasms
Humans
Hydroxyurea
Male
Middle Aged
Neoplasm Staging
Paclitaxel
Remission Induction

authors with profiles

Kerstin Stenson